Polar Capital Funds plc - Biotechnology Fund

Polar Capital Biotechnology Fund provides active exposure to global biotech companies. Designed for investors seeking long-term growth in the healthcare sector.

ISIN IE00B3VXGD32TER 1.63% TERInception 01 Dec 2009Policy AccumulatingProvider Polar Capital

See below how EuroFolio members build portfolios around IE00B3VXGD32, and which ETFs they most commonly pair with it.

Fund Details

Index TrackedNASDAQ Biotechnology

ReplicationPhysical

StrategyLong-only

Currency RiskCurrency unhedged

Fund DomicileIreland

Fund CurrencyUSD